Articles Archives - Page 338 of 771

TuesdayMar 22, 2022 9:15 am

Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) Announces Next Segment in Far-Reaching ‘Psychedelics for Alcoholism’ Series

Clearmind Medicine (CSE: CMND) (FSE: CWY0), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics, has announced the fifth webinar in its Psychedelics for Alcoholism series. This segment is titled “Psychedelics for Alcoholism, Q&A with Clearmind Management.” Scheduled for March 30, 2022, this insightful event will feature Clearmind CEO Adi Zuloff-Shani and business development VP Mark Haden. The two experts will discuss the effects of alcohol use disorder (“AUD”) and provide an overview of the company’s proprietary psychoactive molecule, MEAI. In addition, the webinar will include a question-and-answer session, during which key personnel will answer questions related…

TuesdayMar 22, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces First Phase of Epilepsy Research Using DehydraTECH(TM)-CBD

Lexaria’s patented DehydraTECH(TM) technology provides faster delivery times, increases bioavailability, increases brain absorption, improves drug potency, reduces administration costs, and masks unwanted flavors The epilepsy research will compare the FDA-approved Epidiolex(R) to the company’s proprietary DehydraTECH-CBD formulation The global cannabidiol (“CBD”) market had an estimated value of $2.7 billion in 2021 and is expected to reach $111.8 billion by 2030, driven by an increase in demand for CBD use in health and wellness industries Lexaria Bioscience (NASDAQ: LEXX) (NASDAQ: LEXXW), a global innovator in drug delivery platforms, recently announced that the first phase of its epilepsy research program, EPIL-A21-1, has…

TuesdayMar 22, 2022 9:00 am

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Launches New European Routing Nodes, Now Providing Nine Active Nodes on Lightning Network

LQwD has recently deployed additional routing nodes in Europe, namely in Italy, Sweden, Ireland, England and France Since the US-West deployment in November 2021, LQwD has seen 157 nodes interconnected with more than 158 transaction channels over 10 Bitcoin through all channels Arcane Research predicts that there will be as many as 700 million Lightning Network users by 2030 The global cryptocurrency market is expected to reach US$4.94 billion by 2030 LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF), an emerging technology company developing payment infrastructure for the Bitcoin Lightning Network, has announced the deployment of additional European routing nodes. The…

TuesdayMar 22, 2022 9:00 am

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Prepares Summer Gold Exploration Program in Ontario, Amid European War Era Instability

StraightUp Resources is a mining acquisition and exploration company with flagship properties in Ontario, Canada, and an expanding international footprint Following on the acquisition of aerial digital magnetic survey data last year for its flagship properties, the company is preparing a summer work program that will include analysis of its data, identification of key geological targets, and geophysical sampling including a drill program The war Russia launched in Ukraine last month has driven some new interest in gold amid concerns about the war’s potential far-reaching impact as well and the immediate impact on Russia’s and the world economy as a…

MondayMar 21, 2022 9:15 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Intellectual Property Portfolio Grows Following Receipt of 24th Granted Patent

Lexaria has received a new patent entitled “Compositions Infused with Nicotine Compounds and Methods of Use Thereof” The new patent, granted in Australia, is the first awarded from Lexaria’s 8th patent family and offers IP protection across a total of 9 claims Lexaria believes the patent could be meaningful as it seeks to build value With the new patent, Lexaria’s IP portfolio has now grown to 24 granted patents worldwide In his letter to shareholders dated January 27, 2022, Lexaria Bioscience (NASDAQ: LEXX) CEO Chris Bunka documented the company’s expectation that it would receive additional patents in 2022. The expected…

MondayMar 21, 2022 9:00 am

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF), a 2022 Year Outlook

Eat Well Group forecasts approximately CAD$60 million in revenue for 2021 It projects $90-$110 million in revenue for the 2022 calendar year, representing a double-digit growth rate for the company This growth will be primarily attributed to increased online sales through Walmart’s e-commerce platform, along with sales in brick and mortar stores at Walmart, Loblaws and HEB Grocery Eat Well Group also looks to grow its market reach through forging relationships and distribution partnerships with key players in the industry The 2021 calendar year was successful for Eat Well Investment Group (CSE: EWG) (OTC: EWGFF). Most notably, the company has…

MondayMar 21, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Writing the Playbook on M&A

Flora Growth’s two late 2021 acquisitions added an estimated $35 million in revenue and $7 million in EBITDA Its acquisition of Vessel Brand Inc. is projected to bring $35-$45 million in revenue for the 2022 calendar year With these acquisitions, the company, an internationally focused cannabis brand builder with a global distribution platform, stamps its position as an undisputed market and M&A leader In 2021, Flora Growth (NASDAQ: FLGC) completed its Initial Public Offering (“IPO”) and closed the acquisition of Vessel Brand Inc., a direct-to-consumer (“DTC”) business. The company also formed a joint venture to see the KaLaya brand's distribution…

MondayMar 21, 2022 9:00 am

2022 Virtual Growth Conference to Feature Roundtables, Fireside Chats with 250+ Companies

Companies and investors are encouraged to attend the 2022 Virtual Growth Conference being held as a virtual gathering March 28-30, 2022. The Virtual Growth Conference, organized by Maxim Group LLC and hosted by M-Vest, will provide a unique opportunity for attendees to interact with institutional investors and executives from 250+ companies. This year’s gathering will feature leaders from a diverse collection of industry sectors, including biotech, clean energy, electric vehicles, financial services, fintech & REITs, gaming & entertainment, healthcare, healthcare IT, infrastructure, shipping and technology/media/telecom. To RSVP for your virtual seat, visit https://ibn.fm/2022VirtualGrowth The 2022 Virtual Growth Conference kicks off…

FridayMar 18, 2022 2:30 pm

SRAX Inc. (NASDAQ: SRAX) Giving Execs a New Way to Get Investor’s Attention

In an age where investors are inundated with information and companies struggle to engage investors, SRAX provides an innovative platform for both, complete with due diligence tools, a large investor community and events SRAX expects full-year 2022 revenue of $46-$48 million, up 46%-52% over unaudited 2021 revenue Keeping investors’ attention has historically been hard, but it’s even more difficult today. As we entered the digital age and the flood of information becomes readily available, like the emergence of social media, prevalence of Reg As, and multitude of websites peddling more pump than fact, means keeping investor’s attention is even harder.…

FridayMar 18, 2022 9:15 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Offers a Glimpse into its R&D Pipeline, Patent Strategies, and Clinical Trials at March Investor Conferences

Mydecine participated in this year’s Annual Roth Conference, the Oppenheimer & Co. Annual Healthcare Conference, and will be at the upcoming Maxim Group’s Virtual Growth Conference These conferences represent an opportunity for the company to share its R&D pipeline, patent strategies and ongoing clinical trials Mydecine’s management has optimism for the future, as it taps into the growing psychedelics therapeutics and smoking cessation markets Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) has been at the forefront of developing novel psychedelic and non-psychedelic molecules for medical use. Its research and development efforts have focused on compounds that can enable safer and…

Site Search

Company Search

Category: Articles

Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) Announces Next Segment in Far-Reaching ‘Psychedelics for Alcoholism’ Series

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces First Phase of Epilepsy Research Using DehydraTECH(TM)-CBD

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Launches New European Routing Nodes, Now Providing Nine Active Nodes on Lightning Network

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Prepares Summer Gold Exploration Program in Ontario, Amid European War Era Instability

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Intellectual Property Portfolio Grows Following Receipt of 24th Granted Patent

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF), a 2022 Year Outlook

Flora Growth Corp. (NASDAQ: FLGC) Writing the Playbook on M&A

2022 Virtual Growth Conference to Feature Roundtables, Fireside Chats with 250+ Companies

SRAX Inc. (NASDAQ: SRAX) Giving Execs a New Way to Get Investor’s Attention

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Offers a Glimpse into its R&D Pipeline, Patent Strategies, and Clinical Trials at March Investor Conferences

Market Basics

Newsletter Publishers

Public Companies